Comparison of PathVysion and INFORM Fluorescence In Situ Hybridization Kits for Assessment of HER-2/neu Status in Breast Carcinoma

被引：0
|
作者：
Sanjay Kakar
Nick Puangsuvan
Jane M. Stevens
Romualda Serenas
George Mangan
Shalini Sahai
Michael L. Mihalov
机构：
[1] University of Illinois at Chicago,Department of Pathology
来源：
Molecular Diagnosis | 2000年 / 5卷 / 3期
关键词：
PathVysion; INFORM; prognosis; immunohistochemistry;
D O I：
10.1007/BF03262076
中图分类号：
学科分类号：
摘要：
Background: Fluorescence in situ hybridization is advocated for precise assessment of HER-2/neu status in breast carcinoma; however, few objective data compare available kits for clinical laboratories contemplating development of the test.
引用
收藏
页码：193 / 197
页数：4
相关论文
共 50 条
  • [1] Comparison of PathVysion and INFORM fluorescence in situ hybridization kits for assessment of HER-2/neu status in breast carcinoma
    Kakar, S
    Puangsuvan, N
    Stevens, JM
    Serenas, R
    Mangan, G
    Sahai, S
    Mihalov, ML
    MOLECULAR DIAGNOSIS, 2000, 5 (03): : 193 - 197
  • [2] Comparison of immunohistochemical and fluorescence in situ hybridization assessment for topoisomerase IIalpha gene and HER-2/NEU status in breast carcinoma
    Neagu, M.
    Andrei, F.
    Butur, G.
    Diana, T.
    Georgescu, A.
    Ardeleanu, C.
    FEBS JOURNAL, 2008, 275 : 340 - 340
  • [3] Comparison of fluorescence in situ hybridization and immunohistochemical analysis for HER-2/neu detection in breast carcinoma.
    Li, Y
    Battaglia, T
    Davis, M
    Hankins, L
    Hagemeister, S
    Arthur, T
    Tawfik, O
    Persons, D
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (04) : 641 - 642
  • [4] Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer
    Jacobs, TW
    Gown, AM
    Yaziji, H
    Barnes, MJ
    Schnitt, SJ
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 1974 - 1982
  • [5] Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma
    Gong, Y
    Booser, DJ
    Sneige, N
    CANCER, 2005, 103 (09) : 1763 - 1769
  • [6] Assessment of HER-2/Neu status by immunohistochemistry and fluorescence in situ hybridization in mammary Paget disease and underlying carcinoma
    Anderson, JM
    Ariga, R
    Govil, H
    Bloom, KJ
    Francescatti, D
    Reddy, VB
    Gould, VE
    Gattuso, P
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2003, 11 (02) : 120 - 124
  • [7] Comparison of fluorescence in situ hybridization and immunohistochemistry for assessment of HER-2 status in breast cancer patients
    Lin Wang
    Xiaobei Wang
    Xiu Nie
    Ling Ma
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2009, 29 : 354 - 358
  • [8] Comparison of Fluorescence in situ Hybridization and Immunohistochemistry for Assessment of HER-2 Status in Breast Cancer Patients
    Wang, Lin
    Wang, Xiaobei
    Nie, Xiu
    Ma, Ling
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2009, 29 (03) : 354 - 358
  • [9] Comparison of Fluorescence in situ Hybridization and Immunohistochemistry for Assessment of HER-2 Status in Breast Cancer Patients
    王琳
    王晓蓓
    聂秀
    马玲
    Current Medical Science, 2009, 29 (03) : 354 - 358
  • [10] Evaluation of HER-2 status in breast carcinoma by fluorescence in situ hybridization and immunohistachemistry
    Ogura H.
    Akiyama F.
    Kasumi F.
    Kazui T.
    Sakamoto G.
    Breast Cancer, 2003, 10 (3) : 234 - 240
12345